Log in to MyACC
Journal Wrap
The hottest research from various peer-reviewed journals – handpicked weekly by the ACC.org Editorial Board led by Kim A. Eagle, MD, MACC.
Are DOACs Safe in Morbidly Obese Patients With Nonvalvular AFib?
A new study published in the American Journal of Cardiovascular Drugs suggests the use of direct oral anticoagulants (DOACs) are not associated with increased risk of thromboembolic events or bleeding in in morbidly obese patients with nonvalvular atrial fibrillation (AFib).
CTCR-MVS: Concomitant Tricuspid Repair in Patients With MR
Concomitant tricuspid annuloplasty in patients undergoing mitral valve (MV) surgery was associated with less progression to severe tricuspid regurgitation (TR) over two years, compared with MV surgery alone, according to results from the CTCR-MVS trial presented during AHA 2021 and simultaneously published in the New England Journal of Medicine.
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Valvular Heart Disease, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Novel Agents, Mitral Regurgitation
Keywords: ACC Publications, Cardiology Magazine, Dabigatran, Rivaroxaban, Atrial Fibrillation, Retrospective Studies, Quality of Life, Obesity, Morbid, Tricuspid Valve Insufficiency, Tricuspid Valve, Mitral Valve, Mitral Valve Insufficiency, Anticoagulants, Incidence, Reoperation, Prevalence, Ethnic Groups, Dilatation, Confidence Intervals, Follow-Up Studies, Arm, Body Mass Index, Functional Status, Thrombosis, Myocardial Infarction, Risk Factors, Stroke, Hemostasis, Pacemaker, Artificial, Venous Thrombosis, Embolism
< Back to Listings
